Facially Amphiphilic Skeleton-Derived Antibacterial Cationic Dendrimers

Area of Science:

• Materials Science
• Biochemistry
• Nanotechnology

Background:

• Microbial infections present a significant global health challenge, necessitating the development of novel, biocompatible, and highly effective antimicrobial agents.
• Existing antimicrobial strategies face limitations due to rising resistance and potential toxicity, driving research into alternative therapeutic approaches.

Purpose of the Study:

• To design and synthesize novel cationic dendrimers incorporating facially amphiphilic bile acid skeletons for enhanced antimicrobial properties.
• To evaluate the antibacterial efficacy, biocompatibility, and in vivo therapeutic potential of these novel dendrimers.

Main Methods:

• Synthesis of cationic dendrimers D-CA6-N+ (G2) and D-CA2-N+ (G1) by modifying facially amphiphilic bile acids with quaternary ammonium charges.
• Characterization of self-assembly into nanostructured micelles in aqueous solutions.
• Determination of minimum inhibitory concentrations (MICs) against Staphylococcus aureus and Escherichia coli, assessment of hemolysis and cytotoxicity, and in vivo efficacy studies in comparison to penicillin G.

Main Results:

• Dendrimers D-CA6-N+ and D-CA2-N+ self-assembled into nanostructured micelles.
• D-CA6-N+ exhibited potent antibacterial activity against S. aureus (MIC: 7.50 μM) and E. coli (MIC: 7.79 μM), demonstrating superior efficacy compared to D-CA2-N+.
• D-CA6-N+ showed negligible hemolysis and cytotoxicity, and in vivo studies indicated enhanced efficacy and safety over penicillin G for S. aureus infection treatment and wound healing.

Conclusions:

• Facially amphiphilic skeleton-derived cationic dendrimers represent a promising strategy for developing advanced antibacterial agents with improved efficacy and biocompatibility.
• The unique structure facilitates selective bacterial membrane disruption, leading to potent antimicrobial action with minimal host cell damage.
• These findings highlight the potential of D-CA6-N+ as a safe and effective therapeutic agent for bacterial infections and wound management.